{"title": "The Functional Medicine Approach to COVID-19: Virus-Specific Nutraceutical and Botanical Agents | The Institute for Functional Medicine", "author": null, "url": "https://www.ifm.org/news-insights/the-functional-medicine-approach-to-covid-19-virus-specific-nutraceutical-and-botanical-agents/", "hostname": "ifm.org", "description": "Assesses the scientific plausibility of promising prevention approaches and therapeutic interventions and offers clinical recommendations.", "sitename": "The Institute for Functional Medicine", "date": "2020-03-31", "cleaned_text": "References Zinc 1) Fischer WC, Black RE. Zinc and the risk for infectious disease. Annu Rev Nutr. 2004;24:255-275. doi: Laakko T, Vollmer TL. The dynamic link between the integrity of the immune system and zinc status. J Nutr. 2000;130(5S Suppl):1399S-1406S. doi: [10.1093/jn/130.5.1399S](https://dx.doi.org/10.1093/jn/130.5.1399S) 3) Shankar AH, Prasad AS. Zinc and immune function: the biological basis of altered resistance to infection. Am J Clin Nutr. 1998;68(2 Suppl):447S-463S. doi: [10.1093/ajcn/68.2.447S](https://dx.doi.org/10.1093/ajcn/68.2.447S) 4) Gao H, Dai W, Zhao L, Min J, Wang F. The role of zinc and zinc homeostasis in macrophage function. J GE, et al. Serum zinc and pneumonia in nursing home elderly. Am J Clin Nutr. 2007;86(4):1167-1173. doi: [10.1093/ajcn/86.4.1167](https://doi.org/10.1093/ajcn/86.4.1167) 6) Barnett JB, et al. Effect of zinc supplementation on serum zinc concentration and T cell proliferation in nursing home elderly: a randomized, van Hemert MJ. Zn(2+) inhibits coronavirus arterivirus RNA polymerase activity in vitro and zinc ionophores block the replication of these viruses in cell culture. Pathog. Zinc supplementation promotes a Th1 response and improves clinical symptoms in fewer hours in children with pneumonia younger than 5 years old. A randomized controlled clinical trial. Front Pediatr. 2019;7:431. doi: [10.3389/fped.2019.00431](https://doi.org/10.3389/fped.2019.00431) 10) Finzi E. Treatment of SARS-CoV-2 with high dose oral zinc salts: a report on four patients. Int J Infect Dis. 2020;99:307-309. doi: [10.1016/j.ijid.2020.06.00](https://doi.org/10.1016/j.ijid.2020.06.006) 11) Rerksuppaphol S, Rerksuppaphol L. A randomized controlled trial of zinc supplementation in the treatment of acute respiratory tract infection in Thai children. Pediatr Rep. 2019;11(2):7954. doi: [10.4081/pr.2019.7954](https://doi.org/10.4081/pr.2019.7954) 12) King JC, Brown KH, Gibson RS, et al. Biomarkers of nutrition for development review. J Nutr. 2015;146(4):858S-885S. doi: [10.3945/jn.115.220079](https://doi.org/10.3945/jn.115.220079) Page JB, Campa A. Randomized, controlled clinical trial of zinc supplementation to prevent immunological failure in HIV-infected adults. Duque-Molina M, V\u00e1squez-Trespalacios EM, S\u00e1nchez-Garz\u00f3n J. Effect of zinc on immune recovery in HIV patients. Medell\u00edn 2013. Randomized controlled trial. CES Medicina. 2017;31(1):3-13. doi: [10.21615/cesmedicina.31.1.1](https://dx.doi.org/10.21615/cesmedicina.31.1.1) Elderberry 15) Porter RS, Bode RF. A review of the antiviral properties of black elder (Sambucus nigra L.) products. Phytother Res. 2017;31(4):533-554. doi: [10.1002/ptr.5782](https://doi.org/10.1002/ptr.5782) 16) C, Zuckerman DM, Brantley S, et al. Sambucus nigra extracts inhibit infectious bronchitis virus at an early point during replication. BMC Vet Res. 2014;10:24. doi: [10.1186/1746-6148-10-24](https://doi.org/10.1186/1746-6148-10-24) 17) Barak V, Halperin T, Kalickman I. The effect of Sambucol, a black elderberry-based, natural product, on the production of human cytokines: I. inflammatory cytokines. Eur Cytokine Netw. 2001;12(2):290-296. 18) Barak V, Birkenfeld S, Halperin T, Kalickman I. The effect of herbal remedies on the production of human inflammatory and anti-inflammatory cytokines. Isr Med Assoc J. 2002;4(11 Center. Natural Medicines Database: Elderberry. [https://naturalmedicines.therapeuticresearch.com/databases/food,-herbs-supplements/professional.aspx](https://naturalmedicines.therapeuticresearch.com/databases/food,-herbs-supplements/professional). Accessed March 30, 2020. 20) Ulbricht C, Basch E, Cheung L, et al. An evidence-based systematic review of elderberry and elderflower (Sambucus nigra) by the Natural Standard Research Collaboration. J Diet Suppl. 2014;11(1):80-120. doi: [10.3109/19390211.2013.859852](https://doi.org/10.3109/19390211.2013.859852) 21) Frank T, Janssen M, Netzet G, Christian B, Bitsch I, Netzel M. Absorption and excretion of elderberry (Sambucus of Sambucus nigra and Aronia melanocarpa extracts Impact of dietary anthocyanins on systemic and vascular inflammation: systematic review and meta-analysis randomised clinical trials. Food Chem Toxicol. 2020;135:110922. doi: [10.1016/j.fct.2019.110922](https://doi.org/10.1016/j.fct.2019.110922) 24) Li S, Wu B, Fu W, Reddivari L. The anti-inflammatory effects of dietary anthocyanins against ulcerative Int T, Wadstein J. Randomized study of the efficacy and safety of oral elderberry extract in the treatment of influenza A and B virus infections. J Int Med Res. 2004;32(2):132-140. doi: [10.1177/147323000403200205](https://doi.org/10.1177/147323000403200205) 26) Zakay-Rones Z, Varsano N, Zlotnik M, et al. Inhibition of several strains of influenza virus in vitro and reduction of symptoms by an elderberry extract (Sambucus nigra L.) during an outbreak of influenza B Panama. J Altern Complement Med. 1995;1(4):361-369. doi: [10.1089/acm.1995.1.361](https://doi.org/10.1089/acm.1995.1.361) 27) Tiralongo E, Wee SS, Lea RA. Elderberry supplementation reduces cold duration and symptoms in air-travellers: placebo-controlled clinical trial. Med Lett Drugs Ther. 2019;61(1566):32. [https://secure.medicalletter.org/w1566f](https://secure.medicalletter.org/w1566f). 29) Hawkins J, Baker L, Dunne E. Black elderberry (Sambucus nigra) supplementation effectively treats upper respiratory symptoms: a controlled clinical trials. Complement Ther [10.1016/j.ctim.2018.12.004](https://doi.org/10.1016/j.ctim.2018.12.004) 30) Curtis PJ, Kroon PA, Hollands WJ, et al. Cardiovascular disease risk biomarkers and liver and kidney function are not altered in postmenopausal women after ingesting an elderberry extract rich in anthocyanins for 12 weeks. J Nutr. 2009;139(12):2266-2271. doi: [10.3945/jn.109.113126](https://doi.org/10.3945/jn.109.113126) Vitamin D 31) Mawson AR. Role of fat-soluble vitamins A and D in the pathogenesis of influenza: a new perspective. Int Sch Res Notices. 2013;2013:246737. doi: [10.5402/2013/246737](https://doi.org/10.5402/2013/246737) 32) Martineau AR, Jolliffe DA, Greenberg L, et al. Vitamin D supplementation to prevent acute respiratory infections: individual participant data meta-analysis. Health Technol Assess. 2019;23(2):1-44. doi: [10.3310/hta23020](https://doi.org/10.3310/hta23020) 33) Zhou J, Du J, Huang L, Wang Y, Shi Y, Lin H. Preventive effects of vitamin D on seasonal influenza A in infants: multicenter, randomized, open, controlled clinical trial. Pediatr doi: [10.1097/INF.0000000000001890](https://doi.org/10.1097/INF.0000000000001890) 34) Tzilas V, Bouros E, Barbayianni I, et al. Vitamin D prevents experimental lung fibrosis and predicts survival in patients Bergandi L, Aldieri E, Silvagno F. Vitamin D inhibits the epithelial-mesenchymal transition by a negative feedback regulation of TGF- activity. J Steroid TGF- induced epithelial-mesenchymal transition [10.1186/s12931-014-0146-6](https://doi.org/10.1186/s12931-014-0146-6) Hiemstra PS. TGF-1 impairs vitamin D-induced and constitutive airway defense mechanisms. J Innate Immun. 2020;12(1):74-89. doi: [10.1159/000497415](https://doi.org/10.1159/000497415) 38) Liu 2010;48(1):1-15. doi: [10.1016/j.freeradbiomed.2009.09.026](https://doi.org/10.1016/j.freeradbiomed.2009.09.026) 39) Lu L, Lu Q, Chen W, Li J, Li C, Zheng Z. Vitamin D3 protects against diabetic retinopathy by inhibiting high-glucose-induced activation of the ROS/TXNIP/NLRP3 inflammasome pathway. J Diabetes Res. 2018;2018:8193523. doi: [10.1155/2018/8193523](https://doi.org/10.1155/2018/8193523) 40) Rao Z, Chen X, Wu J, et al. Vitamin D receptor inhibits NLRP3 activation by impeding its BRCC3-mediated deubiquitination. Front Immunol. 2019;10:2783. [10.3389/fimmu.2019.02783](https://doi.org/10.3389/fimmu.2019.02783) 41) Proc Nutr Soc. D [1,25(OH)2D3] differentially regulates human innate cytokine responses to bacterial versus viral pattern recognition receptor stimuli. J Immunol. 2016;196(7):2965-2972. doi: [10.4049/jimmunol.1500460](https://doi.org/10.4049/jimmunol.1500460) 43) Zdrenghea MT, Makrinioti H, Bagacean Bush A, Johnston SL, Stanciu LA. Vitamin D modulation of innate immune responses to respiratory viral infections. Rev Med Virol. 2017;27(1). doi: [10.1002/rmv.1909](https://doi.org/10.1002/rmv.1909) 44) Verway M, Bouttier M, al. Vitamin D induces interleukin-1 expression: paracrine macrophage epithelial doi: [10.1371/journal.ppat.1003407](https://doi.org/10.1371/journal.ppat.1003407) 45) Tulk SE, Liao KC, Muruve DA, Li Y, Beck PL, MacDonald JA. Vitamin D3 metabolites enhance the NLRP3-dependent secretion of [10.1002/jcb.24985](https://doi.org/10.1002/jcb.24985) MT, Kattan M, Fennoy I, et al. Randomized phase 2 trial of monthly vitamin D to prevent respiratory complications in children with sickle cell disease. Blood Adv. 2018;2(9):969-978. doi: [10.1182/bloodadvances.2017013979](https://doi.org/10.1182/bloodadvances.2017013979) 47) Autier P, Mullie P, Macacu al. Effect of vitamin D supplementation on non-skeletal disorders: a systematic review of et al. Effect of monthly, high-dose, long-term vitamin D on lung function: a randomized controlled trial. Nutrients. 2017;9(12):E1353. doi: [10.3390/nu9121353](https://doi.org/10.3390/nu9121353) 49) Turin A, Bax JJ, Doukas D, et al. Interactions among vitamin D, atrial fibrillation, and the renin-angiotensin-aldosterone system. Am J Cardiol. Williams JS, Vaidya A. A randomized intervention study to evaluate the effect of calcitriol therapy on the renin-angiotensin system JB, et al. Investigating the association of vitamin D with blood pressure and the renin-angiotensin-aldosterone system in hypertensive subjects: a cross-sectional prospective study. J [10.1038/s41371-017-0005-2](https://doi.org/10.1038/s41371-017-0005-2) 52) Zittermann A, Ernst JB, Prokop et al. Effects of vitamin D supplementation on renin and aldosterone concentrations in patients with advanced heart failure: the EVITA trial. Int J Endocrinol. 2018;2018:5015417. doi: [10.1155/2018/5015417](https://doi.org/10.1155/2018/5015417) 53) Yang P, Gu H, Zhao al. Angiotensin-converting enzyme 2 (ACE2) mediates influenza Sci Rep. 2014;4:7027. doi: [10.1038/srep07027](https://doi.org/10.1038/srep07027) 54) Xu J, Yang J, Chen J, Luo Q, Zhang Q, Zhang H. Vitamin D alleviates lipopolysaccharide-induced acute lung injury via regulation of the renin-angiotensin system. Mol Med Rep. 2017;16(5):7432-7438. doi: [10.3892/mmr.2017.7546](https://doi.org/10.3892/mmr.2017.7546) 55) Scragg R. The vitamin D assessment (ViDA) study - design and main findings. J Steroid Biochem Biol. AL, et al. Randomized trial of vitamin D supplementation and risk of acute respiratory infection in Mongolia. Pediatrics. 2012;130(3):e561-e567. doi: [10.1542/peds.2011-3029](https://doi.org/10.1542/peds.2011-3029) 57) Sanders KM, Stuart AL, Williamson EJ, et al. Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. et al. Monthly high-dose vitamin D treatment for the prevention of functional decline: a randomized clinical trial. JAMA Intern Med. 2016;176(2):175-183. doi: [10.1001/jamainternmed.2015.7148](https://doi.org/10.1001/jamainternmed.2015.7148) 59) JB. Effects of vitamin D supplementation in atorvastatin-treated patients: a new drug interaction Vieth R, Chan PC, MacFarlane GD. Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level. Am J Clin Nutr. 2001;73(2):288-294. doi: [10.1093/ajcn/73.2.288](https://doi.org/10.1093/ajcn/73.2.288) 62) Bradley R, Schloss J, Brown D, et al. The effects of vitamin D on acute viral respiratory infections: a rapid review. Adv Z, et al. Monthly high-dose vitamin D supplementation does not increase kidney stone risk or serum calcium: results from a randomized controlled trial. Am J Clin Nutr. 2019;109(6):1578-1587. doi: [10.1093/ajcn/nqy378](https://doi.org/10.1093/ajcn/nqy378) Vitamin A 64) Huang Z, Liu Y, Qi G, Brand D, Zheng SG. Role of vitamin A in the immune system. J Clin Med. 2018;7(9):258. doi: [10.3390/jcm7090258](https://doi.org/10.3390/jcm7090258) 65) Cui D, Moldoveanu Z, Stephensen CB. High-level dietary vitamin A enhances T-helper type 2 cytokine production and secretory immunoglobulin A response to influenza A virus infection in BALB/c mice. J Nutr. 2000;130(5):1132-1139. doi: [10.1093/jn/130.5.1132](https://doi.org/10.1093/jn/130.5.1132) 66) Rodr\u00edguez A, Hamer DH, Rivera J, et al. Effects of moderate doses of vitamin A as an adjunct to the treatment of pneumonia in underweight and normal-weight children: D, et al. Vitamin A supplementation was associated with reduced mortality in patients with Ebola virus disease during the West African outbreak. J Nutr. 2019;149(10):1757-1765. doi: [10.1093/jn/nxz142](https://doi.org/10.1093/jn/nxz142) 68) et al. A randomized trial of vitamin A supplements in relation to mortality among human immunodeficiency virus-infected and uninfected children in Tanzania. Pediatr Infect doi: [10.1097/00006454-199902000-00009](https://doi.org/10.1097/00006454-199902000-00009) 69) Bhandari N, Bhan MK, Sazawal S. Impact of massive dose of vitamin A given to preschool children with acute diarrhoea on subsequent respiratory and diarrhoeal morbidity. BMJ. 1994;309(6966):1404-1407. doi: [10.1136/bmj.309.6966.1404](https://doi.org/10.1136/bmj.309.6966.1404) 70) Rothman KJ, Moore Singer MR, Nguyen US, Mannino S, Milunsky A. Teratogenicity of high vitamin A intake. N Engl J Med. 1995;333(21):1369-1373. doi: [10.1056/NEJM199511233332101](https://doi.org/10.1056/NEJM199511233332101) 71) Bartlett H, Eperjesi F. Possible contraindications and adverse reactions associated with the use of ocular nutritional supplements. Ophthalmic Physiol Opt. 2005;25(3):179-194. doi: [10.1111/j.1475-1313.2005.00294.x](https://doi.org/10.1111/j.1475-1313.2005.00294.x) 72) Bendich A, Am J Clin Nutr. 1989;49(2):358-371. doi: [10.1093/ajcn/49.2.358](https://doi.org/10.1093/ajcn/49.2.358) 73) Cruz S, da Cruz SP, Ramalho A. Impact of vitamin A supplementation on pregnant women and on women who have just given birth: a systematic review. J by dietary supplements: a tabular Int J Mol 2016;17(4):537. doi: [10.3390/ijms17040537](https://dx.doi.org/10.3390%2Fijms17040537) 76) Bitarafan S, Saboor-Yaraghi A, Sahraian MA, et al. Effect of vitamin A supplementation on fatigue and depression in multiple sclerosis patients: a double-blind placebo-controlled clinical trial. Iran J Allergy Asthma Kowalski TE, Falestiny M, Furth E, Malet Vitamin A hepatotoxicity: a cautionary note regarding 25,000 IU supplements. Am J Med. 1994;97(6):523-528. doi: [10.1016/0002-9343(94)90347-6](https://doi.org/10.1016/0002-9343(94)90347-6) Vitamin C 78) Carr AC, Maggini S. Vitamin C and Immune Function. Nutrients. 2017;9(11):1211. doi: [10.3390/nu9111211](https://doi.org/10.3390/nu9111211) 79) Zabet MH, Mohammadi M, Ramezani H. Effect of high-dose ascorbic acid on vasopressor's requirement in septic shock. J Res Pharm [10.4103/2279-042X.179569](https://doi.org/10.4103/2279-042x.179569) 80) Fowler AA, Truwit JD, Hite RD, et al. Effect of vitamin C infusion on organ failure and biomarkers of inflammation and vascular injury in patients with sepsis and severe acute respiratory failure. JAMA. 2019;322(13):1261-1270. doi: [10.1001/jama.2019.11825](https://doi.org/10.1001/jama.2019.11825) 81) Schloss J, Lauche R, Harnett J, et al. Efficacy and safety of vitamin C in the management of acute respiratory infection and disease: a rapid review. Adv Integr Med. 2020;7(4):187-191. Zhang Vitamin C supplementation in the critically ill: a systematic review and meta-analysis. SAGE Open Med. 2018;6:2050312118807615. doi: [10.1177/2050312118807615](https://doi.org/10.1177/2050312118807615) 83) Merlin \u00c9, Pereira B, Cabaillot A. Efficacy of vitamin C for the prevention and treatment of upper respiratory tract infection. A meta-analysis in children. Eur J Clin Pharmacol. 2019;75(3):303-311. doi: [10.1007/s00228-018-2601-7](https://doi.org/10.1007/s00228-018-2601-7) 84) Therapeutic Research Center. Natural Medicines Database: Vitamin C. [https://naturalmedicines.therapeuticresearch.com/databases/food,-herbs-supplements/professional.aspx](https://naturalmedicines.therapeuticresearch.com/databases/food,-herbs-supplements/professional.aspxproductid=434#adverseEvents). Accessed September 21, 2020. 85) Food and Nutrition Board, Institute of Medicine. Dietary reference intakes for vitamin C, vitamin E, selenium, and carotenoids. National Academy Press. [http://www.nap.edu/books/0309069351/html/](http://www.nap.edu/books/0309069351/html/). Published 2000. Accessed September 21, 2020. N-ACETYLCYSTEINE (NAC) 86) McCarty MF, DiNicolantonio JJ. Nutraceuticals have potential for boosting the type 1 interferon response to RNA viruses including influenza and coronavirus. Prog Cardiovasc Dis. 2020;63(3):383-385. doi: Attenuation of influenza-like symptomatology and improvement of cell-mediated Respir A. A review of N-acetyl cysteine. Cell J. 2017;19(1):11-17. doi: [10.22074/cellj.2016.4872](https://dx.doi.org/10.22074%2Fcellj.2016.4872) 89) Bauer Colpo GD, et al. A double-blind, randomized, placebo-controlled study of aspirin and N-acetylcysteine as adjunctive for bipolar depression. J Clin Psychiatry. doi: [10.4088/JCP.18m12200](https://doi.org/10.4088/JCP.18m12200) 90) Berk M, Turner A, Malhi GS, et al. A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo [published al. Phase I randomized clinical trial of N-acetylcysteine in combination with an adjuvant probenecid for treatment of severe traumatic brain injury in children. PLoS One. 2017;12(7):e0180280. doi: [10.1371/journal.pone.0180280](https://dx.doi.org/10.1371%2Fjournal.pone.0180280) 92) Bhatti J, Nascimento B, Akhtar U, et al. Systematic review of human and animal studies examining the efficacy and safety of N-acetylcysteine (NAC) and N-acetylcysteine amide (NACA) in traumatic brain injury: impact on neurofunctional outcome and biomarkers of oxidative Massoudifar A, Abaszadeh S. and of N-acetyl-cysteine for prophylaxis of ventilator-associated pneumonia: a randomized, double 2018;8(1):19-23. doi: [10.4103/2045-9912.229599](https://doi.org/10.4103/2045-9912.229599) QUERCETIN 94) Dostal quercetin on microRNA expression: a critical review. Czech Repub. Natural Medicines Database: Quercetin. [https://naturalmedicines.therapeuticresearch.com/databases/food,-herbs-supplements/professional.aspx\"](https://naturalmedicines.therapeuticresearch.com/databases/food,-herbs-supplements/professional.aspx). Accessed September 21, 2020. 96) Wu W, Li R, Li X, et al. Quercetin as an antiviral agent inhibits influenza A virus (IAV) entry. Viruses. 2015;8(1):6. 97) Kinker B, Comstock AT, Sajjan US. Quercetin: a promising treatment for the common cold. J Anc Dis Prev Rem. 2014;2:2:1000111. doi: [10.4172/2329-8731.1000111](https://doi.org/10.4172/2329-8731.1000111) 98) Somerville VS, Braakhuis AJ, Hopkins WG. Effect of flavonoids on upper respiratory tract infections and immune function: a systematic review and meta-analysis. Adv Nutr. 2016;7(3):488-497. doi: [10.3945/an.115.010538](https://doi.org/10.3945/an.115.010538) 99) Qiu X, S, et al. Prophylactic efficacy of quercetin 3--O-D-glucoside against Ebola virus infection. Antimicrob Agents Chemother. 2016;60(9):5182-5188. doi: [10.1128/AAC.00307-16](https://doi.org/10.1128/AAC.00307-16) 100) Wong G, He S, Siragam V, et al. Antiviral activity of quercetin-3--O-D-glucoside against Zika virus infection. Virol Sin. 2017;32(6):545-547. doi: [10.1007/s12250-017-4057-9](https://doi.org/10.1007/s12250-017-4057-9) 101) Tozs\u00e9r on inflammasome activation during inflammatory Mol Nutr Food Res. 2018;62(13):e1800147. doi: [10.1002/mnfr.201800147](https://doi.org/10.1002/mnfr.201800147) 103) Nieman DC, Henson DA, Gross SJ, et al. Quercetin reduces illness but not immune perturbations after intensive exercise. Med Sci Sports Exerc. 2007;39(9):1561-1569. doi: [10.1249/mss.0b013e318076b566](https://doi.org/10.1249/mss.0b013e318076b566) 104) Andres S, Pevny S, Ziegenhagen R, et al. Safety aspects of the use of quercetin as a dietary supplement. Mol Nutr Food [10.1002/mnfr.201700447](https://doi.org/10.1002/mnfr.201700447) Kujawski R, et al. Pharmacological effect of quercetin in hypertension and its potential application in pregnancy-induced hypertension: review of in vitro, in vivo, and clinical studies. Evid Based Complement Alternat A, J. Quercetin in men with category III chronic prostatitis: preliminary prospective, double-blind, placebo-controlled trial. 107) Andres S, Pevny S, Ziegenhagen R, et al. Safety aspects of the use of quercetin as a dietary supplement. I, Rasul A, Ali M. Identification of potent COVID-19 main protease (Mpro) inhibitors from natural polyphenols: an in silico strategy unveils a hope against CORONA. Preprints. 2020;2020030333. doi: [10.20944/preprints202003.0333.v1](https://www.preprints.org/manuscript/202003.0333/v1) 109) Sagesaka YM. Effects of green tea catechins and theanine on preventing influenza infection among healthcare workers: a randomized controlled trial. BMC Complement Altern Med. 2011;11:15. doi: [10.1186/1472-6882-11-15](https://dx.doi.org/10.1186%2F1472-6882-11-15) 110) Lee HE, Yang G, Park YB, et al. Epigallocatechin-3-gallate prevents acute gout by suppressing NLRP3 inflammasome activation and mitochondrial DNA synthesis. Molecules. 2019;24(11):2138. doi: [10.3390/molecules24112138](https://doi.org/10.3390/molecules24112138) 111) Furushima D, Nishimura T, Takuma N, et al. Prevention of acute upper respiratory infections by consumption of catechins in healthcare workers: a randomized, Mol Sci. 2011;12(9):5592-5603. doi: [10.3390/ijms12095592](https://dx.doi.org/10.3390%2Fijms12095592) 113) Chow HH, Cai Y, Hakim IA, et al. Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals. Clin Cancer Res. 2003;9(9):3312-3319. 114) Isomura T, Suzuki S, Origasa H, et al. Liver-related safety assessment of green tea extracts in humans: a systematic review of randomized controlled trials [published correction appears in Eur DN, Barrett ML, Chavez ML, et al. Safety of green tea extracts: a systematic review by the US Pharmacopeia. Drug Saf. 2008;31(6):469-484. doi: [10.2165/00002018-200831060-00003](https://doi.org/10.2165/00002018-200831060-00003) 116) Oketch-Rabah HA, Roe AL, Rider CV, et al. United States Pharmacopeia (USP) comprehensive review of the hepatotoxicity of green tea extracts. Toxicol Rep. 2020;7:386-402. doi: [10.1016/j.toxrep.2020.02.008](https://dx.doi.org/10.1016%2Fj.toxrep.2020.02.008) 117) Younes M, Aggett P, Aguilar F, et al. Scientific opinion on the safety of green tea catechins. EFSA J. 2018;16(4):e05239. doi: [10.2903/j.efsa.2018.5239](https://efsa.onlinelibrary.wiley.com/doi/10.2903/j.efsa.2018.5239) 118) Isomura T, Suzuki S, Origasa H, et al. Liver-related safety assessment of green tea extracts in humans: a systematic review of randomized controlled trials [published correction appears in Eur Samavat H, Bedell S, et al. The safety of green tea extract supplementation in postmenopausal women at risk for breast cancer: results of the Minnesota Green Tea Trial. Food Chem Toxicol. 2015;83:26-35. doi: [10.1016/j.fct.2015.05.019](https://doi.org/10.1016/j.fct.2015.05.019) 120) Chen IJ, Liu CY, Chiu JP, Hsu CH. Therapeutic effect of high-dose green tea extract on weight Shao A, Dolan LC, Griffiths JC. Bioactive nutrients - time for tolerable upper intake levels to address safety. Regul Toxicol Paola R, Cuzzocrea S. Protective effect of epigallocatechin-3-gallate (EGCG) in diseases with uncontrolled immune activation: could such a scenario be helpful to counteract COVID-19?. Int J Mol Sci. 2020;21(14):5171. doi: [10.3390/ijms21145171](https://doi.org/10.3390/ijms21145171) 123) Hu J, Webster D, Cao J, Shao A. The safety of green tea and green tea extract consumption in adults - results of a systematic review. Regul Toxicol S. Potential inhibitor of COVID-19 main protease (Mpro) from several medicinal plant compounds by molecular docking study. Preprints. 2020, 2020030226. doi: [10.20944/preprints202003.0226.v1](https://www.preprints.org/manuscript/202003.0226/v1) CURCUMIN 125) Sun Y, Liu W, Zhang H, et al. Curcumin prevents osteoarthritis by inhibiting the activation of inflammasome NLRP3. J Interferon Cytokine Res. 2017;37(10):449-455. doi: [10.1089/jir.2017.0069](https://doi.org/10.1089/jir.2017.0069) 126) Yin H, Guo Q, Li X, et al. Curcumin suppresses IL-1 secretion and prevents J Immunol. 2018;200(8):2835-2846. doi: [10.4049/jimmunol.1701495](https://doi.org/10.4049/jimmunol.1701495) 127) Gong S, Zhou J, et al. Curcumin alleviates DSS-induced colitis via Immunol. 2018;104:11-19. doi: [10.1016/j.molimm.2018.09.004](https://doi.org/10.1016/j.molimm.2018.09.004) 128) Zhao J, Wang J, Zhou M, Li M, Li M, Tan H. Curcumin attenuates al. Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases. Br J Pharmacol. 2017;174(11):1325-1348. doi: [10.1111/bph.13621](https://dx.doi.org/10.1111/bph.13621) 130) Chainani-Wu N. Safety a component DY, WS. A meta-analysis of the clinical use of curcumin for irritable bowel syndrome (IBS). J Clin Med. 2018;7(10):298. [10.3390/jcm7100298](https://dx.doi.org/10.3390%2Fjcm7100298) 133) a review. J Ethnopharmacol. 2017;209:1-12. doi: [10.1016/j.jep.2017.07.022](https://doi.org/10.1016/j.jep.2017.07.022) 134) Xu J, Qiu JC, Ji X, et al. Potential pharmacokinetic herb-drug interactions: have we overlooked the importance of human 1 and 2 Curr Drug Metab. 2019;20(2):130-137. Zaltman C, Soares-Mota M. The use of curcumin as a complementary therapy in ulcerative colitis: a systematic review of randomized controlled clinical trials. Nutrients. 2020;12(8):2296. doi: [10.3390/nu12082296](https://doi.org/10.3390/nu12082296) 136) Cheng AL, Hsu CH, Lin JK, et al. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res. 2001;21(4B):2895-2900. 137) Amalraj A, Varma K, Jacob J, et al. A novel highly bioavailable curcumin formulation improves symptoms and diagnostic indicators a randomized, double-blind, J Endocrinol. 2017;2017:1835195. doi: [10.1155/2017/1835195](https://doi.org/10.1155/2017/1835195) 139) Zhou Y, Hou Y, Shen J, Huang Y, Martin W, Cheng F. Network-based drug repurposing [10.1038/s41421-020-0153-3](https://doi.org/10.1038/s41421-020-0153-3) MELATONIN 140) Wang X, Ni L, et al. COVID-19: melatonin as a potential adjuvant treatment. Life Sci. 2020;250:117583. doi: [10.1016/j.lfs.2020.117583](https://doi.org/10.1016/j.lfs.2020.117583) 141) Foley HM, Steel AE. Adverse events associated with oral administration of melatonin: a critical systematic review of clinical evidence. Complement Ther Med. 2019;42:65-81. doi: [10.1016/j.ctim.2018.11.003](https://doi.org/10.1016/j.ctim.2018.11.003) 142) Andersen LP, G\u00f6genur I, Rosenberg J, Reiter RJ. The safety A, Petrie KJ. Melatonin for the prevention and treatment of jet lag. Database Syst Rev. 2002;2:CD001520. A, D, Riera R. Melatonin for preventing J Clin Pract. 2018;72(7):e13203. 145) Abdelgadir IS, Gordon MA, Akobeng AK. Melatonin for the management of sleep problems in children with neurodevelopmental disorders: a systematic review and meta-analysis. Arch [10.1136/archdischild-2017-314181](https://doi.org/10.1136/archdischild-2017-314181) 146) Besag FMC, Vasey MJ, Lao KSJ, Wong ICK. Adverse events associated with melatonin for the treatment of primary or secondary sleep disorders: a systematic review. CNS Drugs. 2019;33(12):1167-1186. doi: [10.1007/s40263-019-00680-w](https://doi.org/10.1007/s40263-019-00680-w) 147) NG, I, Rosenberg J. Clinical pharmacokinetics of melatonin: a systematic Eur Oral melatonin reduces blood coagulation activity: a placebo-controlled study in healthy men. 2008;44(2):127-133. doi: [10.1111/j.1600-079X.2007.00499.x](https://doi.org/10.1111/j.1600-079X.2007.00499.x) 149) Rajaratnam SMW, Cain SW. The SSRI citalopram increases the sensitivity of the human circadian system to light in an acute dose. Psychopharmacology cytokines and oxidative stress markers in remitting Arch Med Res. 2018;49(6):391-398. doi: Faramarzi E. A double-blind, placebo-controlled trial related to the effects of melatonin on oxidative stress and inflammatory parameters of Wang TT, Effective Lessey BA, Savaris RF. The use of resveratrol as an adjuvant treatment of pain in endometriosis: a randomized clinical trial. J Endocr Soc. 2017;1(4):359-369. doi: [10.1210/js.2017-00053](https://dx.doi.org/10.1210%2Fjs.2017-00053) 155) Shaito A, Posadino AM, Younes N, et al. Potential adverse effects of resveratrol: a literature review. Int J Mol Sci. 2020;21(6):2084. doi: [10.3390/ijms21062084](https://doi.org/10.3390/ijms21062084) 156) Salehi M, sword health benefits. Biomedicines. 2018;6(3):91. doi: [10.3390/biomedicines6030091](https://dx.doi.org/10.3390%2Fbiomedicines6030091) 157) Patel KR, Scott E, Brown VA, Gescher AJ, Steward WP, Brown K. Clinical trials of resveratrol. Ann N Y Acad Sci. Paine MF. Herb-drug interactions: challenges and improved predictions. Drug Metab Dispos. 2014;42(3):301-317. doi: [10.1124/dmd.113.055236](https://doi.org/10.1124/dmd.113.055236) 159) European Food Safety Authority. Safety of synthetic trans-resveratrol as a novel food pursuant to Regulation (EC) No 258/97. EFSA J. 2016;14:1-30. doi: [10.2903/j.efsa.2016.4368](https://doi.org/10.2903/j.efsa.2016.4368) 160) Turner RS, Craft S, et al. A randomized, double-blind, placebo-controlled resveratrol for Motechin Holz MK. The therapeutic potential of trials. NPJ Precis JM, et al. Effect of resveratrol on walking performance in older people with peripheral artery disease: the RESTORE randomized clinical trial. JAMA 163) Anton Embry C, et al. Safety and metabolic outcomes of resveratrol supplementation in older adults: doi: [10.1016/j.exger.2014.05.015](https://doi.org/10.1016/j.exger.2014.05.015) References - 1) Fischer WC, Black RE. Zinc and the risk for infectious disease. Annu Rev Nutr. 2004;24:255-275. doi:10.1146/annurev.nutr.23.011702.073054 - 2) Fraker PJ, King LE, Laakko T, Vollmer TL. The dynamic link between the integrity of the immune system and zinc status. J Nutr. 2000;130(5S Suppl):1399S-1406S. doi:10.1093/jn/130.5.1399S - 3) Shankar AH, Prasad AS. Zinc and immune function: the biological basis of altered resistance to infection. Am J Clin Nutr. 1998;68(2 Suppl):447S-463S. doi:10.1093/ajcn/68.2.447S - 4) Gao H, Dai W, Zhao L, Min J, Wang F. The role of zinc and zinc homeostasis in macrophage function. J Immunol Barnett JB, Dallal GE, et al. Serum zinc and pneumonia in nursing home elderly. Am J Clin Nutr. 2007;86(4):1167-1173. doi:10.1093/ajcn/86.4.1167 - 6) Barnett JB, Dao MC, DH, et al. Effect of zinc supplementation on serum zinc concentration and T cell proliferation in nursing home elderly: a randomized, double-blind, placebo-controlled M, essential 2016;611:58-65. doi:10.1016/j.abb.2016.03.022 - 8) te Velthuis AC, van Hemert MJ. Zn(2+) inhibits coronavirus arterivirus RNA polymerase activity in vitro and zinc ionophores block the replication of these viruses in cell culture. PLoS Pathog. 2010;6(11):e1001176. doi:10.1371/journal.ppat.1001176 Zinc supplementation promotes a Th1 response and improves clinical symptoms in fewer hours in children with pneumonia younger than 5 years old. A randomized controlled clinical trial. Front Pediatr. 2019;7:431. doi:10.3389/fped.2019.00431 - 10) Finzi E. Treatment of SARS-CoV-2 with high dose oral zinc salts: a report on four patients. Int J Infect Dis. 2020;99:307-309. doi:10.1016/j.ijid.2020.06.00 - 11) Rerksuppaphol S, Rerksuppaphol L. A randomized controlled trial of zinc supplementation in the treatment of acute respiratory tract infection in Thai children. Pediatr Rep. 2019;11(2):7954. doi:10.4081/pr.2019.7954 - 12) King JC, Brown KH, Gibson RS, et al. Biomarkers of nutrition for development (BOND)-zinc review. J Nutr. 2015;146(4):858S-885S. doi:10.3945/jn.115.220079 - 13) Baum S, Sales S, Page JB, Campa A. Randomized, controlled clinical trial of zinc supplementation to prevent immunological failure in HIV-infected adults. Clin Infect 2010;50(12):1653-1660. 14) Contreras-Mart\u00ednez H, Duque-Molina M, V\u00e1squez-Trespalacios EM, S\u00e1nchez-Garz\u00f3n J. Effect of zinc on immune recovery in HIV patients. Medell\u00edn 2013. Randomized controlled trial. CES Medicina. 2017;31(1):3-13. doi:10.21615/cesmedicina.31.1.1 - 15) Porter RS, Bode RF. A review of the antiviral properties of black elder (Sambucus nigra L.) products. Phytother Res. 2017;31(4):533-554. doi:10.1002/ptr.5782 - 16) Chen C, Zuckerman DM, Brantley S, et al. Sambucus nigra extracts inhibit infectious bronchitis virus at an early point during replication. BMC Vet Res. 2014;10:24. doi:10.1186/1746-6148-10-24 - 17) Barak V, Halperin T, Kalickman I. The effect of Sambucol, a black elderberry-based, natural product, on the production of human cytokines: I. inflammatory cytokines. Eur Cytokine Netw. 2001;12(2):290-296. - 18) Barak V, Birkenfeld S, Halperin T, Kalickman I. The effect of herbal remedies on the production of human inflammatory and anti-inflammatory cytokines. Isr Med Assoc J. 2002;4(11 Suppl):919-922. Research Center. Natural Medicines Database: Elderberry. https://naturalmedicines.therapeuticresearch.com/databases/food,-herbs-supplements/professional.aspx?productid=434#adverseEvents. Accessed March 30, 2020. - 20) Ulbricht C, Basch E, Cheung L, et al. An evidence-based systematic review of elderberry and elderflower (Sambucus nigra) by the Natural Standard Research Collaboration. J Diet Suppl. 2014;11(1):80-120. doi:10.3109/19390211.2013.859852 - 21) Frank T, Janssen M, Netzet G, Christian B, Bitsch I, Netzel M. Absorption and excretion of elderberry (Sambucus Effects of Sambucus nigra and Aronia melanocarpa extracts 2015;53(4):533-539. P, Jafari T. Impact of dietary anthocyanins on systemic and vascular inflammation: systematic review and meta-analysis on randomised clinical trials. Food Chem Toxicol. 2020;135:110922. doi:10.1016/j.fct.2019.110922 - 24) Li S, Wu B, Fu W, Reddivari L. The anti-inflammatory effects of dietary anthocyanins against ulcerative colitis. Int J Mol Sci. 2019;20(10):2588. Z, Thom E, Wollan T, Wadstein J. Randomized study of the efficacy and safety of oral elderberry extract in the treatment of influenza A and B virus infections. J Int Med Res. 2004;32(2):132-140. doi:10.1177/147323000403200205 - 26) Zakay-Rones Z, Varsano N, Zlotnik M, et al. Inhibition of several strains of influenza virus in vitro and reduction of symptoms by an elderberry extract (Sambucus nigra L.) during an outbreak of influenza B Panama. J Altern Complement Med. 1995;1(4):361-369. doi:10.1089/acm.1995.1.361 - 27) Tiralongo E, Wee SS, Lea RA. Elderberry supplementation reduces cold duration and symptoms in air-travellers: a randomized, double-blind placebo-controlled clinical trial. Nutrients. 2016;8(4):182. influenza. Med Lett Drugs Ther. 2019;61(1566):32. https://secure.medicalletter.org/w1566f. - 29) Hawkins J, Baker Cherry L, Dunne E. Black elderberry (Sambucus nigra) supplementation effectively treats upper respiratory symptoms: a randomized, controlled clinical trials. Complement Ther Med. 2019;42:361-365. doi:10.1016/j.ctim.2018.12.004 - 30) Curtis PJ, Kroon PA, Hollands WJ, et al. Cardiovascular disease risk biomarkers and liver and kidney function are not altered in postmenopausal women after ingesting an elderberry extract rich in anthocyanins for 12 weeks. J Nutr. 2009;139(12):2266-2271. doi:10.3945/jn.109.113126 - 31) Mawson AR. Role of fat-soluble vitamins A and D in the pathogenesis of influenza: a new perspective. Int Sch Res Notices. 2013;2013:246737. doi:10.5402/2013/246737 - 32) Martineau AR, Jolliffe DA, Greenberg L, et al. Vitamin D supplementation to prevent acute respiratory infections: individual participant data meta-analysis. Health Technol Assess. 2019;23(2):1-44. doi:10.3310/hta23020 - 33) Zhou J, Du J, Huang L, Wang Y, Shi Y, Lin H. Preventive effects of vitamin D on seasonal influenza A in infants: multicenter, randomized, open, controlled clinical trial. Pediatr Infect Dis 2018;37(8):749-754. doi:10.1097/INF.0000000000001890 - 34) Tzilas V, Bouros E, Barbayianni I, et al. Vitamin D prevents experimental lung fibrosis and predicts survival in patients with idiopathic pulmonary fibrosis. Pharmacol M, Bergandi L, Aldieri E, Silvagno F. Vitamin D inhibits the epithelial-mesenchymal transition by a negative feedback regulation of TGF-? activity. J Steroid Biochem Mol Biol. 2019;187:97-105. doi:10.1016/j.jsbmb.2018.11.006 D regulating TGF-? induced epithelial-mesenchymal transition appears in 2014;15:146. doi:10.1186/s12931-014-0146-6 - 37) Schrumpf der AM, Hiemstra PS. TGF-?1 impairs vitamin D-induced and constitutive airway epithelial host defense mechanisms. J Innate Immun. 2020;12(1):74-89. doi:10.1159/000497415 - 38) Liu RM, Biol Med. 2010;48(1):1-15. doi:10.1016/j.freeradbiomed.2009.09.026 - 39) Lu L, Lu Q, Chen W, Li J, Li C, Zheng Z. Vitamin D3 protects against diabetic retinopathy by inhibiting high-glucose-induced activation of the ROS/TXNIP/NLRP3 inflammasome pathway. J Diabetes Res. 2018;2018:8193523. doi:10.1155/2018/8193523 - 40) Rao Z, Chen X, Wu J, et al. Vitamin D receptor inhibits NLRP3 activation by impeding its BRCC3-mediated deubiquitination. Front Immunol. 2019;10:2783. doi:10.3389/fimmu.2019.02783 - 41) Hewison function: an overview. Proc Nutr Soc. 2012;71(1):50-61. doi:10.1017/S0029665111001650 - KT. Vitamin D [1,25(OH)2D3] differentially regulates human innate cytokine responses to bacterial versus viral pattern recognition receptor stimuli. J Immunol. 2016;196(7):2965-2972. doi:10.4049/jimmunol.1500460 - 43) Zdrenghea MT, Makrinioti H, Bagacean C, Bush A, Johnston SL, Stanciu LA. Vitamin D modulation of innate immune responses to respiratory viral infections. Rev Med Virol. 2017;27(1). doi:10.1002/rmv.1909 - 44) Verway M, Bouttier M, Wang et al. Vitamin D induces interleukin-1? expression: paracrine macrophage epithelial signaling controls 2013;9(6):e1003407. doi:10.1371/journal.ppat.1003407 - 45) Tulk SE, Liao KC, Muruve DA, Li Y, Beck PL, MacDonald JA. Vitamin D3 metabolites enhance the NLRP3-dependent secretion of cells. 2015;116(5):711-720. doi:10.1002/jcb.24985 - 46) Lee MT, Kattan M, Fennoy I, et al. Randomized phase 2 trial of monthly vitamin D to prevent respiratory complications in children with sickle cell disease. Blood Adv. 2018;2(9):969-978. doi:10.1182/bloodadvances.2017013979 - 47) Autier P, Mullie P, Macacu A, et al. Effect of vitamin D supplementation on non-skeletal disorders: a systematic review of meta-analyses and Sluyter JD, Camargo CA, Waayer D, et al. Effect of monthly, high-dose, long-term vitamin D on lung function: a randomized controlled trial. Nutrients. 2017;9(12):E1353. doi:10.3390/nu9121353 - 49) Turin A, Bax JJ, Doukas D, et al. Interactions among vitamin D, atrial fibrillation, and the renin-angiotensin-aldosterone system. Am J Cardiol. 2018;122(5):780-784. doi:10.1016/j.amjcard.2018.05.013 - 50) GK, Williams JS, Vaidya A. A randomized intervention study to evaluate the effect of calcitriol therapy on the renin-angiotensin system in diabetes. Corcuff JB, et al. Investigating the association of vitamin D with blood pressure and the renin-angiotensin-aldosterone system in hypertensive subjects: a cross-sectional prospective study. J Hum Hypertens. 2018;32(2):114-121. doi:10.1038/s41371-017-0005-2 - 52) Zittermann A, Ernst JB, Prokop S, et al. Effects of vitamin D supplementation on renin and aldosterone concentrations in patients with advanced heart failure: the EVITA trial. Int J Endocrinol. 2018;2018:5015417. doi:10.1155/2018/5015417 - 53) Yang P, Gu H, Zhao Z, et al. Angiotensin-converting enzyme 2 (ACE2) mediates influenza H7N9 virus-induced acute lung injury. Sci Rep. 2014;4:7027. doi:10.1038/srep07027 - 54) Xu J, Yang J, Chen J, Luo Q, Zhang Q, Zhang H. Vitamin D alleviates lipopolysaccharide-induced acute lung injury via regulation of the renin-angiotensin system. Mol Med Rep. 2017;16(5):7432-7438. doi:10.3892/mmr.2017.7546 - 55) Scragg R. The vitamin D assessment (ViDA) study - design and main findings. J Steroid Biochem Mol Biol. 2020;198:105562. doi:10.1016/j.jsbmb.2019.105562 - 56) D, Frazier AL, et al. Randomized trial of vitamin D supplementation and risk of acute respiratory infection in Mongolia. Pediatrics. 2012;130(3):e561-e567. doi:10.1542/peds.2011-3029 - 57) Sanders KM, Stuart AL, Williamson EJ, et al. Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA. B, Orav EJ, et al. Monthly high-dose vitamin D treatment for the prevention of functional decline: a randomized clinical trial. JAMA Intern Med. 2016;176(2):175-183. doi:10.1001/jamainternmed.2015.7148 - 59) Schwartz JB. Effects of vitamin D supplementation in atorvastatin-treated patients: a new drug interaction with an consequence. Ther. doi:10.33549/physiolres.933059 - 61) Vieth R, Chan PC, MacFarlane GD. Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level. Am J Clin Nutr. 2001;73(2):288-294. doi:10.1093/ajcn/73.2.288 - 62) Bradley R, Schloss J, Brown D, et al. The effects of vitamin D on acute viral respiratory infections: a rapid review. Adv Integr Med. 2020;7(4):192-202. doi:10.1016/j.aimed.2020.07.011 - 63) Malihi Z, Lawes Wu Z, et al. Monthly high-dose vitamin D supplementation does not increase kidney stone risk or serum calcium: results from a randomized controlled trial. Am J Clin Nutr. 2019;109(6):1578-1587. doi:10.1093/ajcn/nqy378 - 64) Huang Z, Liu Y, Qi G, Brand D, Zheng SG. Role of vitamin A in the immune system. J Clin Med. 2018;7(9):258. doi:10.3390/jcm7090258 - 65) Cui D, Moldoveanu Z, Stephensen CB. High-level dietary vitamin A enhances T-helper type 2 cytokine production and secretory immunoglobulin A response to influenza A virus infection in BALB/c mice. J Nutr. 2000;130(5):1132-1139. doi:10.1093/jn/130.5.1132 - 66) Rodr\u00edguez A, Hamer DH, Rivera J, et al. Effects of moderate doses of vitamin A as an adjunct to the treatment of pneumonia in underweight and normal-weight children: Aluisio AR, Perera SM, Yam D, et al. Vitamin A supplementation was associated with reduced mortality in patients with Ebola virus disease during the West African outbreak. J Nutr. 2019;149(10):1757-1765. doi:10.1093/jn/nxz142 - 68) Fawzi WW, Mbise RL, Hertzmark E, et al. A randomized trial of vitamin A supplements in relation to mortality among human immunodeficiency virus-infected and uninfected children in Tanzania. Pediatr Infect Dis 1999;18(2):127-133. doi:10.1097/00006454-199902000-00009 - 69) Bhandari N, Bhan MK, Sazawal S. Impact of massive dose of vitamin A given to preschool children with acute diarrhoea on subsequent respiratory and diarrhoeal morbidity. BMJ. 1994;309(6966):1404-1407. doi:10.1136/bmj.309.6966.1404 - 70) Rothman KJ, Moore LL, Singer MR, Nguyen US, Mannino S, Milunsky A. Teratogenicity of high vitamin A intake. N Engl J Med. 1995;333(21):1369-1373. doi:10.1056/NEJM199511233332101 - 71) Bartlett H, Eperjesi F. Possible contraindications and adverse reactions associated with the use of ocular nutritional supplements. Ophthalmic Physiol Opt. 2005;25(3):179-194. doi:10.1111/j.1475-1313.2005.00294.x - 72) Bendich A, Langseth of vitamin A. Am J Clin Nutr. 1989;49(2):358-371. doi:10.1093/ajcn/49.2.358 - 73) Cruz S, da Cruz SP, Ramalho A. Impact of vitamin A supplementation on pregnant women and on women who have just given birth: a systematic review. J Am Coll Nutr. by dietary supplements: a tabular and clinical characteristics. Int J Mol Sci. 2016;17(4):537. doi:10.3390/ijms17040537 - 76) Bitarafan S, Saboor-Yaraghi A, Sahraian MA, et al. Effect of vitamin A supplementation on fatigue and depression in multiple sclerosis patients: a double-blind placebo-controlled clinical trial. Iran J Allergy Asthma Immunol. 2016;15(1):13-19. 77) Kowalski TE, Falestiny M, Furth E, Malet PF. Vitamin A hepatotoxicity: a cautionary note regarding 25,000 IU supplements. Am J Med. 1994;97(6):523-528. doi:10.1016/0002-9343(94)90347-6 - 78) Carr AC, Maggini S. Vitamin C and Immune Function. Nutrients. 2017;9(11):1211. doi:10.3390/nu9111211 - 79) Zabet MH, Mohammadi M, Ramezani M, Khalili H. Effect of high-dose ascorbic acid on vasopressor's requirement in septic shock. J Res Pharm Pract. 2016;5(2):94-100. doi:10.4103/2279-042X.179569 - 80) Fowler AA, Truwit JD, Hite RD, et al. Effect of vitamin C infusion on organ failure and biomarkers of inflammation and vascular injury in patients with sepsis and severe acute respiratory failure. JAMA. 2019;322(13):1261-1270. doi:10.1001/jama.2019.11825 - 81) Schloss J, Lauche R, Harnett J, et al. Efficacy and safety of vitamin C in the management of acute respiratory infection and disease: a rapid review. Adv Integr Med. 2020;7(4):187-191. doi:10.1016/j.aimed.2020.07.008 - 82) Zhang M, Jativa DF. Vitamin C supplementation in the critically ill: a systematic review and meta-analysis. SAGE Open Med. 2018;6:2050312118807615. doi:10.1177/2050312118807615 - 83) Vorilhon P, B, Vaillant Roussel H, Merlin \u00c9, Pereira B, Cabaillot A. Efficacy of vitamin C for the prevention and treatment of upper respiratory tract infection. A meta-analysis in children. Eur J Clin Pharmacol. 2019;75(3):303-311. doi:10.1007/s00228-018-2601-7 - 84) Therapeutic Research Center. Natural Medicines Database: Vitamin C. https://naturalmedicines.therapeuticresearch.com/databases/food,-herbs-supplements/professional.aspx?productid=434#adverseEvents. Accessed September 21, 2020. - 85) Food and Nutrition Board, Institute of Medicine. Dietary reference intakes for vitamin C, vitamin E, selenium, and carotenoids. National Academy Press. http://www.nap.edu/books/0309069351/html/. Published 2000. Accessed September 21, 2020. - 86) McCarty MF, DiNicolantonio JJ. Nutraceuticals have potential for boosting the type 1 interferon response to RNA viruses including influenza and coronavirus. Prog Cardiovasc Dis. 2020;63(3):383-385. doi:10.1016/j.pcad.2020.02.007 - 87) C, Carati L. Attenuation of influenza-like symptomatology and improvement of cell-mediated with long-term N-acetylcysteine treatment. Eur Respir J. 1997;10(7):1535-1541. M, Kalantar SM, Moini A. A review various uses of N-acetyl cysteine. Cell J. 2017;19(1):11-17. doi:10.22074/cellj.2016.4872 - 89) Bauer IE, C, Colpo GD, et al. A double-blind, randomized, placebo-controlled study of aspirin and N-acetylcysteine as adjunctive treatments for bipolar depression. J Clin Psychiatry. 2018;80(1):18m12200. doi:10.4088/JCP.18m12200 - 90) Berk M, Turner A, Malhi GS, et al. A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo [published Bay?r H, et al. Phase I randomized clinical trial of N-acetylcysteine in combination with an adjuvant probenecid for treatment of severe traumatic brain injury in children. PLoS One. 2017;12(7):e0180280. doi:10.1371/journal.pone.0180280 - 92) Bhatti J, Nascimento B, Akhtar U, et al. Systematic review of human and animal studies examining the efficacy and safety of N-acetylcysteine (NAC) and N-acetylcysteine amide (NACA) in traumatic brain injury: impact on neurofunctional outcome and biomarkers of oxidative stress and inflammation. Front 2018;8:744. Mohammadbeigi A, Massoudifar A, Abaszadeh S. and of N-acetyl-cysteine for prophylaxis of ventilator-associated pneumonia: a randomized, double blind, placebo-controlled clinical trial. Med Gas Res. 2018;8(1):19-23. doi:10.4103/2045-9912.229599 - 94) Dostal Z, Modriansky M. The effect of quercetin on microRNA expression: a critical review. Olomouc Czech Repub. 2019;163(2):95-106. Center. Natural Medicines Database: Quercetin. https://naturalmedicines.therapeuticresearch.com/databases/food,-herbs-supplements/professional.aspx?productid=434#adverseEvents. Accessed September 21, 2020. - 96) Wu W, Li R, Li X, et al. Quercetin as an antiviral agent inhibits influenza A virus (IAV) entry. Viruses. 2015;8(1):6. doi:10.3390/v8010006 - 97) Kinker B, Comstock AT, Sajjan US. Quercetin: a promising treatment for the common cold. J Anc Dis Prev Rem. 2014;2:2:1000111. doi:10.4172/2329-8731.1000111 - 98) Somerville VS, Braakhuis AJ, Hopkins WG. Effect of flavonoids on upper respiratory tract infections and immune function: a systematic review and meta-analysis. Adv Nutr. 2016;7(3):488-497. doi:10.3945/an.115.010538 - 99) Qiu X, Kroeker He S, et al. Prophylactic efficacy of quercetin 3-?-O-D-glucoside against Ebola virus infection. Antimicrob Agents Chemother. 2016;60(9):5182-5188. doi:10.1128/AAC.00307-16 - 100) Wong G, He S, Siragam V, et al. Antiviral activity of quercetin-3-?-O-D-glucoside against Zika virus infection. Virol Sin. 2017;32(6):545-547. doi:10.1007/s12250-017-4057-9 - 101) T?zs\u00e9r J, Benk? S. Mediators Inflamm. Regulatory roles flavonoids on inflammasome activation during inflammatory responses. Mol Nutr Food Res. 2018;62(13):e1800147. doi:10.1002/mnfr.201800147 - 103) Nieman DC, Henson DA, Gross SJ, et al. Quercetin reduces illness but not immune perturbations after intensive exercise. Med Sci Sports Exerc. 2007;39(9):1561-1569. doi:10.1249/mss.0b013e318076b566 - 104) Andres S, Pevny S, Ziegenhagen R, et al. Safety aspects of the use of quercetin as a dietary supplement. Mol Nutr Food - Kujawski R, et al. Pharmacological effect of quercetin in hypertension and its potential application in pregnancy-induced hypertension: review of in vitro, in vivo, and clinical studies. Evid Based Complement Alternat Med. 2018;2018:7421489. - Zeitlin SI, Shahed A, Rajfer J. Quercetin in men with category III chronic prostatitis: a preliminary prospective, double-blind, placebo-controlled trial. Urology. 1999;54(6):960-963. doi:10.1016/s0090-4295(99)00358-1 - 107) Andres S, Pevny S, Ziegenhagen R, et al. Safety aspects of the use of quercetin as a dietary supplement. Mol Nutr Food Res. 2018;62(1). - 108) Adem S, Eyupoglu V, Sarfraz I, Rasul A, Ali M. Identification of potent COVID-19 main protease (Mpro) inhibitors from natural polyphenols: an in silico strategy unveils a hope against CORONA. Preprints. 2020;2020030333. doi:10.20944/preprints202003.0333.v1 - 109) Matsumoto K, Yamada H, Takuma Niino H, Sagesaka YM. Effects of green tea catechins and theanine on preventing influenza infection among healthcare workers: a randomized controlled trial. BMC Complement Altern Med. 2011;11:15. doi:10.1186/1472-6882-11-15 - 110) Lee HE, Yang G, Park YB, et al. Epigallocatechin-3-gallate prevents acute gout by suppressing NLRP3 inflammasome activation and mitochondrial DNA synthesis. Molecules. 2019;24(11):2138. doi:10.3390/molecules24112138 - 111) Furushima D, Nishimura T, Takuma N, et al. Prevention of acute upper respiratory infections by consumption of catechins in healthcare workers: a randomized, placebo-controlled trial. Epigallocatechin-3-gallate (EGCG) clinical trials: than promises? Int J Mol Sci. 2011;12(9):5592-5603. doi:10.3390/ijms12095592 - 113) Chow HH, Cai Y, Hakim IA, et al. Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals. Clin Cancer Res. 2003;9(9):3312-3319. - 114) Isomura T, Suzuki S, Origasa H, et al. Liver-related safety assessment of green tea extracts in humans: a systematic review of randomized controlled trials [published correction appears in Eur Sarma DN, Barrett ML, Chavez ML, et al. Safety of green tea extracts: a systematic review by the US Pharmacopeia. Drug Saf. 2008;31(6):469-484. doi:10.2165/00002018-200831060-00003 - 116) Oketch-Rabah HA, Roe AL, Rider CV, et al. United States Pharmacopeia (USP) comprehensive review of the hepatotoxicity of green tea extracts. Toxicol Rep. 2020;7:386-402. doi:10.1016/j.toxrep.2020.02.008 - 117) Younes M, Aggett P, Aguilar F, et al. Scientific opinion on the safety of green tea catechins. EFSA J. 2018;16(4):e05239. doi:10.2903/j.efsa.2018.5239 - 118) Isomura T, Suzuki S, Origasa H, et al. Liver-related safety assessment of green tea extracts in humans: a systematic review of randomized controlled trials [published correction appears in Eur AM, Samavat H, Bedell S, et al. The safety of green tea extract supplementation in postmenopausal women at risk for breast cancer: results of the Minnesota Green Tea Trial. Food Chem Toxicol. 2015;83:26-35. doi:10.1016/j.fct.2015.05.019 - 120) Chen IJ, Liu CY, Chiu JP, Hsu CH. Therapeutic effect of high-dose green tea extract on weight clinical - AA, Erdman JW Jr, Shao A, Dolan LC, Griffiths JC. Bioactive nutrients - time for tolerable upper intake levels to address safety. Regul Toxicol Pharmacol. 2017;84:94-101. Crupi R, Di Paola R, Cuzzocrea S. Protective effect of epigallocatechin-3-gallate (EGCG) in diseases with uncontrolled immune activation: could such a scenario be helpful to counteract COVID-19?. Int J Mol Sci. 2020;21(14):5171. doi:10.3390/ijms21145171 - 123) Hu J, Webster D, Cao J, Shao A. The safety of green tea and green tea extract consumption in adults - results of a systematic review. Regul Toxicol Pharmacol. 2018;95:412-433. Soetjipto S. Potential inhibitor of COVID-19 main protease (Mpro) from several medicinal plant compounds by molecular docking study. Preprints. 2020, 2020030226. doi:10.20944/preprints202003.0226.v1 - 125) Sun Y, Liu W, Zhang H, et al. Curcumin prevents osteoarthritis by inhibiting the activation of inflammasome NLRP3. J Interferon Cytokine Res. 2017;37(10):449-455. doi:10.1089/jir.2017.0069 - 126) Yin H, Guo Q, Li X, et al. Curcumin suppresses IL-1? secretion and prevents inflammasome. J Immunol. 2018;200(8):2835-2846. doi:10.4049/jimmunol.1701495 - 127) Gong Z, Zhao S, Zhou J, et al. Curcumin alleviates DSS-induced colitis via Mol Immunol. 2018;104:11-19. doi:10.1016/j.molimm.2018.09.004 - 128) Zhao J, Wang J, Zhou M, Li M, Li M, Tan H. Curcumin attenuates et al. Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases. Br J Pharmacol. 2017;174(11):1325-1348. doi:10.1111/bph.13621 - 130) Chainani-Wu N. Safety and curcumin: a component tumeric (Curcuma Lim DY, WS. A meta-analysis of the clinical use of curcumin for irritable bowel syndrome (IBS). J Clin Med. 2018;7(10):298. doi:10.3390/jcm7100298 - 133) Bahramsoltani R, Rahimi MH. Pharmacokinetic interactions of conventional drugs: a review. J Ethnopharmacol. 2017;209:1-12. doi:10.1016/j.jep.2017.07.022 - 134) Xu J, Qiu JC, Ji X, et al. Potential pharmacokinetic herb-drug interactions: have we overlooked the importance of 1 and 2? Curr Drug Metab. 2019;20(2):130-137. MD, Ferreira DMTP, Zaltman C, Soares-Mota M. The use of curcumin as a complementary therapy in ulcerative colitis: a systematic review of randomized controlled clinical trials. Nutrients. 2020;12(8):2296. doi:10.3390/nu12082296 - 136) Cheng AL, Hsu CH, Lin JK, et al. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res. 2001;21(4B):2895-2900. - 137) Amalraj A, Varma K, Jacob J, et al. A novel highly bioavailable curcumin formulation improves symptoms and diagnostic indicators a randomized, double-blind, Int J Endocrinol. 2017;2017:1835195. doi:10.1155/2017/1835195 - 139) Zhou Y, Hou Y, Shen J, Huang Y, Martin W, Cheng F. Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2. Cell Discov. 2020;6:14. doi:10.1038/s41421-020-0153-3 - 140) Zhang R, Wang X, Ni L, et al. COVID-19: melatonin as a potential adjuvant treatment. Life Sci. 2020;250:117583. doi:10.1016/j.lfs.2020.117583 - 141) Foley HM, Steel AE. Adverse events associated with oral administration of melatonin: a critical systematic review of clinical evidence. Complement Ther Med. 2019;42:65-81. doi:10.1016/j.ctim.2018.11.003 - 142) Andersen LP, G\u00f6genur I, Rosenberg J, Reiter RJ. The safety of melatonin humans. Clin doi:10.1007/s40261-015-0368-5 - 143) Herxheimer A, Petrie KJ. Melatonin for the prevention and treatment of jet lag. Cochrane Database Syst Rev. 2002;2:CD001520. doi:10.1002/14651858.CD001520 - 144) Adriano A, D, Riera R. Melatonin for preventing systematic review. Int J Clin Pract. 2018;72(7):e13203. doi:10.1111/ijcp.13203 - 145) Abdelgadir IS, Gordon MA, Akobeng AK. Melatonin for the management of sleep problems in children with neurodevelopmental disorders: a systematic review and meta-analysis. Arch Dis Child. doi:10.1136/archdischild-2017-314181 - 146) Besag FMC, Vasey MJ, Lao KSJ, Wong ICK. Adverse events associated with melatonin for the treatment of primary or secondary sleep disorders: a systematic review. CNS Drugs. 2019;33(12):1167-1186. doi:10.1007/s40263-019-00680-w - 147) Harps\u00f8e NG, Andersen LP, G\u00f6genur I, Rosenberg J. Clinical pharmacokinetics of melatonin: a systematic review. Eur J Clin 148) von Oral melatonin reduces blood coagulation activity: a placebo-controlled study in healthy young men. J Pineal Res. 2008;44(2):127-133. doi:10.1111/j.1600-079X.2007.00499.x - 149) McGlashan EM, Nandam LS, DR, Rajaratnam SMW, Cain SW. The SSRI citalopram increases the sensitivity of the human circadian system to light in an acute dose. Psychopharmacology (Berl). doi:10.1007/s00213-018-5019-0 - 150) S\u00e1nchez-L\u00f3pez cytokines and oxidative stress markers in relapsing remitting multiple sclerosis. Arch Med Res. 2018;49(6):391-398. doi:10.1016/j.arcmed.2018.12.004 - Mesri Faramarzi E. A double-blind, placebo-controlled trial related to the effects of melatonin on oxidative stress and inflammatory parameters of obese women. Metab 2015;47(7):504-508. S, Wang TT, Effective MERS-CoV infection by resveratrol. BMC Infect Dis. 2017;17(1):144. doi:10.1186/s12879-017-2253-8 - Mendes Gross LA, EPG, Lessey BA, Savaris RF. The use of resveratrol as an adjuvant treatment of pain in endometriosis: a randomized clinical trial. J Endocr Soc. 2017;1(4):359-369. doi:10.1210/js.2017-00053 - 155) Shaito A, Posadino AM, Younes N, et al. Potential adverse effects of resveratrol: a literature review. Int J Mol Sci. 2020;21(6):2084. doi:10.3390/ijms21062084 - 156) Salehi B, Mishra AP, Nigam M, et al. Resveratrol: a double-edged sword in health benefits. Biomedicines. 2018;6(3):91. doi:10.3390/biomedicines6030091 - 157) Patel KR, Scott E, Brown VA, Gescher AJ, Steward WP, Brown K. Clinical trials of resveratrol. Ann N Y Acad Sci. 2011;1215:161-169. doi:10.1111/j.1749-6632.2010.05853.x - S, Paine MF. Herb-drug interactions: challenges and opportunities for improved predictions. Drug Metab Dispos. 2014;42(3):301-317. doi:10.1124/dmd.113.055236 - 159) European Food Safety Authority. Safety of synthetic trans-resveratrol as a novel food pursuant to Regulation (EC) No 258/97. EFSA J. 2016;14:1-30. doi:10.2903/j.efsa.2016.4368 - 160) Turner RS, Thomas RG, Craft S, et al. A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease. 161) Berman AY, Motechin RA, Wiesenfeld MY, Holz MK. The therapeutic potential of of clinical trials. NPJ Precis Oncol. - 162) McDermott Guralnik JM, et al. Effect of resveratrol on walking performance in older people with peripheral artery disease: the RESTORE randomized clinical trial. JAMA Cardiol. 2017;2(8):902-907. doi:10.1001/jamacardio.2017.0538 163) Anton SD, Embry C, Marsiske et al. Safety and metabolic outcomes of resveratrol supplementation in older adults: "}